drugset / Trial / NCT00670657
CRITIC - Treatment of Candidemia and Invasive Candidiasis
NaSingle-groupOpen-labelTreatment
Summary
Patients will receive 2mg/kg/day IV daily administration of AmBisome® over 30-60 minutes as a reaction to signs/symptoms and positive Candida culture
Timeline
- Start
- 2007-05
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphotericin B | Unknown | 2 mg/kg | Intravenous |